Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Nucleic Acid Test for Epstein-Barr Virus

By HospiMedica staff writers
Posted on 14 Sep 2004
A new nucleic acid test (NAT) has been designed for the detection and quantification of the Epstein-Barr virus (EBV). More...
The assay has received the CE Mark.

Called ReSSQ EBV assay, the test was developed by LightUp Technologies AB (Huddinge, Sweden). The test enables simpler and more accurate identification and quantification of disease-generating organisms. The unique LightUp probe at the heart of the method is designed to work with real-time polymerase chain reaction (PCR) and can be used in many medical applications. The assay is currently validated for use in conjunction with the LightCycler and ABI Prism 7000 SDS real-time PCR instruments.

Pursuant to a distribution agreement in June 2004 between LightUp Technologies and DakoCytomation (Glostrup, Denmark), the assay will be marketed and sold in Europe by DakoCytomation. Later, the assay will be made available throughout the world.

"We are happy to make this product available to clinicians and clinical laboratories involved in the management of immunocompromised patients,” commented Geoff Gower, director of microbiology at DakoCytomation. "EBV infection is, for example, a major risk factor for developing lymphoproliferative disease (PTLD), a life-threatening complication of organ transplantation.”




Related Links:
LightUp Technologies
DakoCytomation

Gold Member
Neonatal Heel Incision Device
Tenderfoot
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Monitor/Defibrillator
Zenix
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.